2026-02-16 12:29:37
PI3K Inhibitors Market Trends & Forecast 2035
Executive Summary The Phosphoinositide 3-Kinase (PI3K) Inhibitors Market was valued at USD 1.29 billion in 2025 and is projected to grow at a CAGR of 7.3%, reaching USD 2.61 billion by 2035. Growth is driven by the increasing incidence of cancers, particularly chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL), alongside advancements in targeted PI3K therapies. The market is...
0 Commenti 0 condivisioni 753 Views 0 Anteprima